Impact of Silicon-based Formulations on Wound Healing of Laser-induced Microscopic Skin Lesions

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 21, 2023

Primary Completion Date

August 31, 2023

Study Completion Date

August 31, 2023

Conditions
Wound Healing
Interventions
DEVICE

Stratacel

Silicone-based formulation registered as a European class IIa, TGA (Therapeutic Goods Administration) and FDA listed Class I medical device (wound dressing).

DEVICE

Stratamed

Silicone-based formulation registered as a European class IIa, TGA (Therapeutic Goods Administration) and FDA listed Class I medical device (wound dressing).

Trial Locations (1)

Unknown

Hôpitaux universitaires de Genève, Geneva

All Listed Sponsors
collaborator

University Hospital, Geneva

OTHER

lead

Stratpharma AG

INDUSTRY